1998
DOI: 10.1006/jsre.1998.5321
|View full text |Cite
|
Sign up to set email alerts
|

Positive Functional Effects of Milrinone and Methylene Blue Are Not Additive in Control and Hypertrophic Canine Hearts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 25 publications
(5 reference statements)
0
3
0
Order By: Relevance
“…The mechanism of this effect differs from those of other vasoactive agents (epinephrine, dopamine, norepinephrine, and isoproterenol), which exert inotropic effects by increasing intracellular cyclic adenosine monophosphate (cAMP) [10][11][12]. In contrast, MB acts through a reduction in intracellular cGMP [13][14][15][16][17][18][19][20]. Because of its unique mechanism of action, MB has been investigated across different clinical scenarios involving treatment-refractory hypotension associated with low SVR such as that occurring during and after cardiopulmonary bypass, sepsis, and liver transplantation [4][5][6][7][8][13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…The mechanism of this effect differs from those of other vasoactive agents (epinephrine, dopamine, norepinephrine, and isoproterenol), which exert inotropic effects by increasing intracellular cyclic adenosine monophosphate (cAMP) [10][11][12]. In contrast, MB acts through a reduction in intracellular cGMP [13][14][15][16][17][18][19][20]. Because of its unique mechanism of action, MB has been investigated across different clinical scenarios involving treatment-refractory hypotension associated with low SVR such as that occurring during and after cardiopulmonary bypass, sepsis, and liver transplantation [4][5][6][7][8][13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…cGMP has been shown to shorten action potential duration, decrease O 2 consumption, and cause negative inotropy (14,23,24,30). cAMP has been shown to cause positive inotropy and also increase myocardial metabolic function (2,8,12,15,21). Increased cAMP causes positive inotropy through increased calcium current, the inward influx of calcium responsible for the initiation of cardiac contraction (8,15,18).…”
mentioning
confidence: 99%
“…There is experimental evidence suggesting that cAMP not only increases the mean open time of each calcium channel but also increases the number of open channels (25). It has also been demonstrated that alterations in cGMP can affect the level of cAMP in the heart and myocytes (10,12). This has suggested that an interaction exists between the second messenger systems mediated by cAMP and cGMP in the regulation of myocardial function.…”
mentioning
confidence: 99%